Makoto Sumitomo

7PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Deep learningMolecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2024
Impact of an enhanced recovery protocol in frail patients after intracorporeal urinary diversion.

Kenji Zennami, Mamoru Kusaka, Shuhei Tomozawa

|Jan 05, 2024
Older versus younger patients in robot-assisted radical cystectomy with intracorporeal ileal conduit comparing safety and clinical outcomes.

Dutsadee Sowanthip, Kenji Zennami, Tanan Bejrananda

|Jun 08, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.

Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh

|Jan 16, 2023
Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.

Takuhisa Nukaya, Makoto Sumitomo, Eiji Sugihara

|Mar 01, 2022
Risk factors for postoperative ileus after robot-assisted radical cystectomy with intracorporeal urinary diversion.

Kenji Zennami, Makoto Sumitomo, Kyu Hasegawa

Pageof 2